Literature DB >> 23990352

The effects of silencing of PI3K p85α on 5-FU-induced colorectal cancer cells apoptosis.

Yan Sun1, Hua Tian, Lin Wang, Hui Yang.   

Abstract

Colorectal cancer is the third most common malignancy worldwide. 5-fluorouracil (5-FU) is the commonly used chemotherapeutic agent, however, more patients develop resistance. Phosphatidylinositol 3-kinases (PI3Ks) play a crucial role in a wide range of cellular processes associated with malignant behavior including cell growth, migration, and survival. In this study, we show increased expression of PI3K p85α during the progression of colorectal cancer. Silencing of PI3K p85α in colorectal cancer cells increased disruption of mitochondrial membrane potential and enhanced 5-FU-induced apoptosis. Furthermore, PI3K p85α-depletion results in activated expression of apoptosis-associated genes Bcl-6, Bim, and Bax. Our results suggest that knockdown of PI3K p85α is a potential therapeutic strategy in the treatment of colorectal cancer.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23990352     DOI: 10.1007/s12032-013-0704-7

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  21 in total

Review 1.  The phosphatidylinositol 3-Kinase AKT pathway in human cancer.

Authors:  Igor Vivanco; Charles L Sawyers
Journal:  Nat Rev Cancer       Date:  2002-07       Impact factor: 60.716

2.  Inhibition of phosphatidylinositol 3-kinase increases efficacy of cisplatin in in vivo ovarian cancer models.

Authors:  Tsuyoshi Ohta; Masahide Ohmichi; Tadashi Hayasaka; Seiji Mabuchi; Maki Saitoh; Jun Kawagoe; Kazuhiro Takahashi; Hideki Igarashi; Botao Du; Masakazu Doshida; Ishida Gabriela Mirei; Teiichi Motoyama; Keiichi Tasaka; Hirohisa Kurachi
Journal:  Endocrinology       Date:  2006-01-05       Impact factor: 4.736

3.  Depletion of PI3K p85alpha induces cell cycle arrest and apoptosis in colorectal cancer cells.

Authors:  Yan Sun; Shiyi Zhao; Hua Tian; Xiaoyun Xie; Faman Xiao; Kang Li; Yugang Song
Journal:  Oncol Rep       Date:  2009-12       Impact factor: 3.906

4.  Comparison of oral capecitabine versus intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study.

Authors:  P M Hoff; R Ansari; G Batist; J Cox; W Kocha; M Kuperminc; J Maroun; D Walde; C Weaver; E Harrison; H U Burger; B Osterwalder; A O Wong; R Wong
Journal:  J Clin Oncol       Date:  2001-04-15       Impact factor: 44.544

5.  Targeted molecular therapy of the PI3K pathway: therapeutic significance of PI3K subunit targeting in colorectal carcinoma.

Authors:  Piotr G Rychahou; Lindsey N Jackson; Scott R Silva; Srinivasan Rajaraman; B Mark Evers
Journal:  Ann Surg       Date:  2006-06       Impact factor: 12.969

6.  Screening and prevention of colorectal cancer in Haining County.

Authors:  S Q Zhang
Journal:  Dis Colon Rectum       Date:  1985-05       Impact factor: 4.585

7.  Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype.

Authors:  N Rampino; H Yamamoto; Y Ionov; Y Li; H Sawai; J C Reed; M Perucho
Journal:  Science       Date:  1997-02-14       Impact factor: 47.728

8.  Insulin-like growth factor-1 prevents loss of electrochemical gradient in cardiac muscle mitochondria via activation of PI 3 kinase/Akt pathway.

Authors:  Hui-Chin Lai; Tsun-Jui Liu; Chih-Tai Ting; Prem M Sharma; Ping H Wang
Journal:  Mol Cell Endocrinol       Date:  2003-07-31       Impact factor: 4.102

9.  Mouse 3T3-L1 cells acquire resistance against oxidative stress as the adipocytes differentiate via the transcription factor FoxO.

Authors:  Takayuki Kojima; Takanari Norose; Keita Tsuchiya; Kazuichi Sakamoto
Journal:  Apoptosis       Date:  2010-01       Impact factor: 4.677

10.  Forkhead transcription factor FOXO subfamily is essential for reactive oxygen species-induced apoptosis.

Authors:  Tomohiro Nakamura; Kazuichi Sakamoto
Journal:  Mol Cell Endocrinol       Date:  2007-10-18       Impact factor: 4.102

View more
  4 in total

1.  High BIM mRNA levels are associated with longer survival in advanced gastric cancer.

Authors:  Nandie Wu; Ying Huang; Zhengyun Zou; Ana Gimenez-Capitan; Lixia Yu; Wenjing Hu; Lijing Zhu; Xia Sun; Jose Javier Sanchez; Wenxian Guan; Baorui Liu; Rafael Rosell; Jia Wei
Journal:  Oncol Lett       Date:  2017-02-01       Impact factor: 2.967

2.  miR-455-5p enhances 5-fluorouracil sensitivity in colorectal cancer cells by targeting PIK3R1 and DEPDC1.

Authors:  Tingting Lou; Luqing Zhang; Zongshan Jin; Chundi Miao; Jinqiu Wang; Kongliang Ke
Journal:  Open Med (Wars)       Date:  2022-04-28

3.  Overexpression of sortilin is associated with 5-FU resistance and poor prognosis in colorectal cancer.

Authors:  Sabrina Blondy; Hugo Talbot; Sofiane Saada; Niki Christou; Serge Battu; Julie Pannequin; Marie-Odile Jauberteau; Fabrice Lalloué; Mireille Verdier; Muriel Mathonnet; Aurélie Perraud
Journal:  J Cell Mol Med       Date:  2020-12-16       Impact factor: 5.310

4.  Actinomycin V Induces Apoptosis Associated with Mitochondrial and PI3K/AKT Pathways in Human CRC Cells.

Authors:  Shiqing Jiang; E Zhang; Hang Ruan; Jiahui Ma; Xingming Zhao; Yaoyao Zhu; Xiaoyu Xie; Ningning Han; Jianjiang Li; Hao Zhang; Weidong Xie; Xia Li
Journal:  Mar Drugs       Date:  2021-10-22       Impact factor: 5.118

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.